|
Volumn 52, Issue 11, 2004, Pages 1965-
|
Switching from donepezil or rivastigmine to galantamine in clinical practice.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBAMIC ACID DERIVATIVE;
DONEPEZIL;
GALANTAMINE;
INDAN DERIVATIVE;
NEUROPROTECTIVE AGENT;
NOOTROPIC AGENT;
PIPERIDINE DERIVATIVE;
RIVASTIGMINE;
ALZHEIMER DISEASE;
HUMAN;
LETTER;
RETROSPECTIVE STUDY;
ALZHEIMER DISEASE;
GALANTAMINE;
HUMANS;
INDANS;
NEUROPROTECTIVE AGENTS;
NOOTROPIC AGENTS;
PHENYLCARBAMATES;
PIPERIDINES;
RETROSPECTIVE STUDIES;
MLCS;
MLOWN;
|
EID: 16544365811
PISSN: 00028614
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1532-5415.2004.52529_3.x Document Type: Letter |
Times cited : (13)
|
References (0)
|